Additive 3D Engineering and Popcorn Therapeutics, winners of CEIN’s “ HEALTH ” Accelerator, which aims to foster new, innovative business projects in the health sector

Both initiatives were awarded the prize jointly in the sixth edition of the program, which awards a prize of 8,000 euros.

Nov. 20, 2026
Health 2026 Accelerator Award Winners

This morning, Juan Luis García, the Regional Minister of Universities, Innovation, and Digital Transformation, presented the award for the best project participating in the “ HEALTH ” Accelerator, an initiative launched by the Government of Navarre through the public entity European Center for Enterprises and Innovation of Navarre (CEIN).

The prize, worth 8,000 euros, was awarded jointly to two projects: Additive 3D Engineering, which focuses on the development of 3D-printed anatomical models and biomimetic tissues for surgical training, technical validation, and preoperative planning, led by Pablo Larumbe and Patxi Larumbe; and Popcorn Therapeutics, a modular system for the administration of triple-action oncolytic adenoviruses that are injected directly into the tumor for patients with life-threatening pediatric brain tumors, led by Iker Ausejo and Marta Alonso.

At the event where the winners were announced, Councilor García emphasized the importance of innovation and entrepreneurship for Navarre, particularly in the field of health, noting that behind every scientific advance there are people waiting for an answer, a more accurate diagnosis, or a more effective treatment. He also praised initiatives such as the “ HEALTH ” Accelerator program, which supports entrepreneurs with innovative ideas in healthcare, as well as business projects that are still in their early stages. The event was also attended by the Director General of Science, Technology, and Innovation, Agurtzane Martínez.

This accelerator program celebrated its sixth edition this year with the goal of supporting entrepreneurs with innovative and unique business ideas related to the healthcare sector, as well as projects that are in the launch phase or have been operating in the market for no more than one year. To this end, CEIN provides participants with specialized training, expert mentoring, and access to the ecosystem, helping them identify their market opportunity and validate their business model.

In addition to the cash prize, which will be used to launch the project, the winners will be able to participate in CEIN’s growth and scaling program HEALTH , ScaleUp 2027, as well as set up shop for six months, free of charge, at the CEIN Innovation Incubator.

The winning initiatives were selected this morning from among the six participants in the acceleration program, who presented their proposals to a jury composed of representatives from the Government of Navarre’s Directorate General of Science, Technology, and Innovation; Navarra Health ; Cluster; Navarrabiomed; the Tudela Health District; Cinfa; and CEIN.

It is worth noting that the “ HEALTH ” Accelerator is part of the CEIN program HEALTH, which provides specialized services to foster, accelerate, and scale innovation and entrepreneurship initiatives in the health sector.

Projects Participating in the " HEALTH " Accelerator 2026

In addition to the winning projects, the following projects have participated in the “ HEALTH ” Accelerator:

ComunicaIA. A digital communication assistant designed to help people with ALS who have lost or are losing the ability to speak, facilitating conversation and generating responses more quickly.

First Assay. A biotech initiative focused on developing a biological testing platform using aquatic models—particularly embryonated eggs and salmonid larvae—with applications in aquaculture, biotechnology, the environment, and cosmetics.

Cancer immunotherapy. A biological immunotherapy drug that is more effective than conventional immunotherapies as a treatment option for patients who do not respond to conventional therapies. 

Diagnostic platform. A software platform for the analysis of electromyographic signals and the diagnosis of neuromuscular diseases that improves the diagnostic efficiency and effectiveness of current commercial EMG devices.


 

 

Filed under

Do you have any questions?

Write to us and we'll get back to you